About
Who We Are
Leadership Team
Board of Directors
Clinical and Scientific Advisors
Contact
Science
Immune Continuum
CCR4 in Inflammation
CCR4 in Cancer
Publications
Pipeline
Snapshot
Tivumecirnon (FLX475)
Discovery Programs
Investors
Corporate Profile
Press Releases
Events and Presentations
Stock Information
Corporate Governance
SEC Filings
Email Alerts
Investor Contact
Investor FAQs
Careers
Culture
Benefits
Open Positions
PRESS RELEASES
Year
2024
2023
2022
2021
2020
Filter
August 31 | 2015
FLX Bio Announces Senior Management Hires and Initiation of Phase 1 Trial of FLX925
February 23 | 2015
Bristol-Myers Squibb To Expand Its Immuno-Oncology Pipeline with Agreement to Acquire Flexus Biosciences, Inc.
You are leaving RAPT.com to go to the eczema clinical trial study site.
